2012
DOI: 10.1136/bmj.e4535
|View full text |Cite
|
Sign up to set email alerts
|

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study

Abstract: Previously described undertreatment of women in secondary prevention of cardiovascular disease was not observed for primary prevention. Low use of statins in older people highlights the need for a stronger evidence base and clearer guidelines for people aged over 75.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(35 citation statements)
references
References 36 publications
(61 reference statements)
2
32
1
Order By: Relevance
“…UK research found significantly lower primary prevention use among older people, despite advancing age being the most important risk factor for vascular disease. 19 The SLSR did not record contraindications to anticoagulants, although US research found low warfarin use even among those with no contraindications. 6 These results provide an example of delay in implementing evidence-based practice.…”
Section: Discussionmentioning
confidence: 99%
“…UK research found significantly lower primary prevention use among older people, despite advancing age being the most important risk factor for vascular disease. 19 The SLSR did not record contraindications to anticoagulants, although US research found low warfarin use even among those with no contraindications. 6 These results provide an example of delay in implementing evidence-based practice.…”
Section: Discussionmentioning
confidence: 99%
“…37 The data support the findings of previous studies that examined the association between age and sex, and prescription of medication for the primary prevention of CVD. 38 In primary prevention, the study showed that younger patients and females are more likely to be prescribed therapy, despite all eligible patients being at high risk of developing CVD by definition. This is interesting and does not suggest that GP prescribing practice is solely based on calculated 10-year CVD risk.…”
Section: Comparison With Existing Literaturementioning
confidence: 99%
“…It is the level of severity of the chronic disease and its associated complications which are actually costly (9,27). This highlights the importance of promoting prevention at all ages (including after age 60 years) to reduce the impact and cost of NCDs (28)(29)(30)(31)(32)(33)(34)(35). Given that every 10% increase in NCDs is estimated to lower annual economic growth by 0.5% (20), the need for NCD prevention, especially in the rapidly growing older population, is substantial.…”
Section: Introductionmentioning
confidence: 99%